Metabolomics & Lipidomics

Enjoy 12 months of our best omics content in once place

Roy Goodacre talks about the biggest breakthroughs in the field, the instrument he couldn’t live without, and what he’d be doing in another life...

Could metabolomics provide any insight into the post-COVID conditions? Timothy Garrett wants to find out...

In 2018, Martin Giera, Mary E. Spilker and Gary Siuzdak shared their love of a special field in “Metabolomics: the Superglue of Omics”

Showcasing some of our most popular articles over the years

Biopharmaceutical development is in need of a speed boost. Multi-omics could be the answer.

Could a new MALD-MSI approach bring unprecedented levels of detail to the study of host-microbe interactions?

How important is patient diversity in Alzheimer's disease research?

We sit down with Timothy Garrett, Director of Experimental Pathology and Associate Professor, Department of Pathology, University of Florida, USA

Kim Ekroos shares how high-resolution ion mobility MS is transforming research into the lipidomics of neurodegenerative diseases